Missing the Bull's Eye

Survey of Ophthalmology

Volumn 52, Issue 4, 2007, Pages 440-442

  Gilbert, Molly E ^a   Savino, Peter J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

chloroquine; hydroxychloroquine; maculopathy; multifocal ERG

Indexed keywords

HYDROXYCHLOROQUINE;

ADULT; ARTICLE; BODY WEIGHT; CASE REPORT; CLINICAL EXAMINATION; ELECTRORETINOGRAM; EYE EXAMINATION; FEMALE; HUMAN; OCULOPLETHYSMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUPIL; RETINA MACULOPATHY; RHEUMATOID ARTHRITIS; VISUAL ACUITY; VISUAL FIELD;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ELECTRORETINOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYCHLOROQUINE; MACULA LUTEA; MIDDLE AGED; RETINAL DISEASES; RISK FACTORS; TIME FACTORS;

EID: 34250161296     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2007.04.001     Document Type: Article

References (18)

1. Bernstein H.N. Ocular safety of hydroxychloroquine. Ann Ophthalmol 23 (1991) 292-296
2. Crew S.J. Chloroquine retinopathy with recovery in early stages. Lancet 4 (1964) 36-38
3. Easterbrook M., and Trope G. Value of Humphrey perimetry in the detection of early chloroquine retinopathy. Lens Eye Toxic Res 6 (1989) 255-268
4. Finbloom D.S., Silver K., Newsome D.A., et al. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol 12 (1985) 692-694
5. Hoobs H., Sorsby A., and Freedman A. Retinopathy following chloroquine therapy. Lancet 2 (1959) 478-480
6. Hood D.C., Frishman L.J., Saszik S., et al. Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci 43 (2002) 1673-1685
7. Lai T.Y., Chan W.M., Li H., et al. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy. Am J Ophthalmol 140 (2005) 794-807
8. Marmor M.F., Carr R.E., Easterbrook M., et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 109 (2002) 1377-1382
9. Maturi R.K., Yu M., and Weleber R.G. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users. Arch Ophthalmol 122 (2004) 973-981
10. Morsman C.D.G., Livesey S.J., Richards I.M., et al. Screening for hydroxychloroquine retinal toxicity: is it necessary?. Eye 4 (1990) 572-576
11. Moschos M.N., Moschos M.M., Apostolopoulos M., et al. Assessing hydroxychloroquine toxicity by the multifocal ERG. Doc Ophthalmol 108 (2004) 47-53
12. Neubauer A.S., Samari-Kermani K., Schaller U., et al. Detecting chloroquine retinopathy: electro-oculogram versus colour vision. Br J Ophthalmol 87 (2003) 902-908
13. Penrose P.J., Tzekov R.T., Sutter E.E., et al. Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine. Retina 23 (2003) 503-512
14. Sassani J.W., Brucker A.J., Cobbs W., et al. Progressive chloroquine retinopathy. Ann Ophthalmol 15 (1983) 19-22
15. Shearer R.V., and Dubois E.L. Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy. Am J Ophthalmol 64 (1967) 245-252
16. So S.C., Hedges T.R., Schuman J.S., et al. Evaluation of hydroxychloroquine retinopathy with multifocal electroretinography. Ophthalmic Surg Lasers Imaging 34 (2003) 251-258
17. Sutter E.E., and Tran D. The field topography of ERG components in man-I. The photopic luminance response. Vision Res 32 (1992) 433-446
18. Weiner A., Sandberg M.A., Gaudio A.R., et al. Hydroxychloroquine retinopathy. Am J Ophthalmol 112 (1991) 528-534